Capital Ii, L.P. Dimension, a director at Odyssey Therapeutics, Inc. (ODTX), acquired 1,111,111 shares of the company's stock on May 12, 2026. The transaction, executed at $18.00 per share, amounted to approximately $20 million.
This significant purchase by an insider often suggests a strong belief in the company's future performance. The buy comes amidst other recent insider activity for ODTX, including purchases and sales by George Simeon and SR ONE CAPITAL MANAGEMENT, LLC on May 11, 2026.
Odyssey Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies. The recent insider transactions, particularly the substantial buy from Capital Ii, L.P. Dimension, will be closely watched by investors for potential signals regarding the company's trajectory.